HomeRLAY • NASDAQ
add
Relay Therapeutics Inc
Previous close
$7.40
Day range
$7.51 - $7.51
Year range
$5.70 - $12.14
Market cap
1.20B USD
Avg Volume
2.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.14M | 0.09% |
Net income | -92.21M | 6.39% |
Net profit margin | — | — |
Earnings per share | -0.69 | 14.81% |
EBITDA | -110.76M | -3.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 688.42M | -21.01% |
Total assets | 772.55M | -19.69% |
Total liabilities | 90.81M | -40.22% |
Total equity | 681.74M | — |
Shares outstanding | 133.89M | — |
Price to book | 1.45 | — |
Return on assets | -34.74% | — |
Return on capital | -36.62% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -92.21M | 6.39% |
Cash from operations | -65.83M | 4.03% |
Cash from investing | 45.55M | -11.17% |
Cash from financing | 1.54M | -25.87% |
Net change in cash | -18.74M | -22.94% |
Free cash flow | -29.54M | 17.09% |
About
Founded
2015
Website
Employees
304
